Abstract
Human type 2 diabetes is characterized by defects in both insulin action and insulin secretion. It has been difficult to identify a single molecular abnormality underlying these features. Insulin-receptor substrates (IRS proteins) may be involved in type 2 diabetes: they mediate pleiotropic signals initiated by receptors for insulin and other cytokines1. Disruption of IRS-1 in mice retards growth, but diabetes does not develop because insulin secretion increases to compensate for the mild resistance to insulin2,3. Here we show that disruption of IRS-2 impairs both peripheral insulin signalling and pancreatic β-cell function. IRS-2-deficient mice show progressive deterioration of glucose homeostasis because of insulin resistance in the liver and skeletal muscle and a lack of β-cell compensation for this insulin resistance. Our results indicate that dysfunction of IRS-2 may contribute to the pathophysiology of human type 2 diabetes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A versatile bioelectronic interface programmed for hormone sensing
Nature Communications Open Access 31 May 2023
-
Deciphering the sex bias in housekeeping gene expression in adipose tissue: a comprehensive meta-analysis of transcriptomic studies
Biology of Sex Differences Open Access 18 April 2023
-
Understanding the contemporary high obesity rate from an evolutionary genetic perspective
Hereditas Open Access 07 February 2023
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout




References
Myers, M. G. J & White, M. F. Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol. 36, 615–658 (1996).
Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B. L. II, Johnson, R. S. & Kahn, C. R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186–190 (1994).
Tamemoto, H.et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182–186 (1994).
Warram, J. H., Rich, S. S. & Krolewski, A. S. Joslin's Diabetes Mellitus (eds Kahn, C. R. & Weir, G. C.) 201–215 (Philadelphia, Lea & Febiger, 1994).
DeFronzo, R. A., Bonadonna, R. C. & Ferrannini, E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15, 318–368 (1992).
Sun, X. J.et al. Role of IRS-2 in insulin an cytokine signalling. Nature 377, 173–177 (1995).
Patti, M. E.et al. 4PS/IRS-2 is the alternative substrate of the insulin receptor in IRS-1 deficient mice. J. Biol. Chem. 270, 24670–246673 (1995).
Ren, J. M.et al. Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J. Clin. Invest. 95, 429–432 (1995).
Backer, J. M.et al. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3′-kinase. Formation of binary and ternary signaling complexes in intact cells. J. Biol. Chem. 268, 8204–8212 (1993).
Cheatham, B.et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase DNA synthesis and glucose transporter translocation. Mol. Cell Biol. 14, 4902–4911 (1994).
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O. & Ui, M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes: studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568–3573 (1994).
Shepherd, P. R., Nave, B. T. & Siddle, K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem. J. 305, 25–28 (1995).
Gabbay, R. A.et al. Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271, 1890–1897 (1996).
Bonner-Weir, S., Scaglia, L., Montana, E., Juang, J. H. & Weir, G. C. in Diabetes 1994 (eds Baba, S. & Kareko, T.) 179–228 (Excerta Medica Int. Congress, 1995).
Scaglia, L., Cahill, C. J., Finegood, D. T. & Bonner-Weir, S. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138, 1736–1741 (1997).
Bruning, J. C., Winnay, J., Cheatham, B. & Kahn, C. R. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1 deficient cells. Mol. Cell Biol. 17, 1513–1521 (1997).
Sun, X. J.et al. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endrocrinol. 11, 251–262 (1997).
Bruning, J. C.et al. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561–572 (1997).
Kloppel, G., Lohr, M., Habich, K., Oberholzer, M., Heitz, P. U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv. Synth. Pathol. Res. 4, 110–125 (1985).
Papaioannou, V., Johnson, R. in Gene Targeting: A Practical Approach (ed. Joyner, A.) Ch. 4, pp. 107–146 (Oxford Univ. Press, Oxford, (1993).
Pons, S.et al. The structure and function of p55PIK reveals a new regulatory subunit for the phosphatidylinositol-3 kinase. Mol. Cell. Biol. 15, 4453–4465 (1994).
Montana, E., Bonner Weir, S. & Weir, G. C. Transplanted beta cell response to increased metabolic demand. Changes in beta cell replication and mass. J. Clin. Invest. 93, 1577–1582 (1994).
Acknowledgements
We thank A. Nagy for R1 cells; M. Ginsberg, M. Petruzelli and M. Taneja for technical support; B. Cheatham for the anti-IRβ antibody. Blastocyst injections were performed in the Core Laboratory of the Diabetes and Endocrinology Research Center, Vanderbilt University. This work was supported by grants from the NIH to G.I.S., S.B.W. and M.F.W. D.J.W. is supported by an MRC (UK) Clinician Scientist Fellowship. D.J.B. was supported by a grant from the JDFI. J.S.G. and D.B. were supported by grants from the Spanish Government.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Withers, D., Gutierrez, J., Towery, H. et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900–904 (1998). https://doi.org/10.1038/36116
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/36116
This article is cited by
-
Understanding the contemporary high obesity rate from an evolutionary genetic perspective
Hereditas (2023)
-
Deciphering the sex bias in housekeeping gene expression in adipose tissue: a comprehensive meta-analysis of transcriptomic studies
Biology of Sex Differences (2023)
-
A versatile bioelectronic interface programmed for hormone sensing
Nature Communications (2023)
-
Targeting pancreatic β cells for diabetes treatment
Nature Metabolism (2022)
-
Diabetic Encephalopathy: Role of Oxidative and Nitrosative Factors in Type 2 Diabetes
Indian Journal of Clinical Biochemistry (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.